Retatrutide 40mg pen

Retatrutide -  is a once-weekly injectable medication being developed by Eli Lilly for obesity, overweight, and type 2 diabetes. It is notable because it is a triple hormone receptor agonist, meaning it activates three different hormone pathways at the same time: GLP-1, GIP, and glucagon.